Search

Displaying results 2801 - 2810 of 10000 in total
  1. Indication

    Locally recurrent Non-Small Cell Lung Carcinoma (NSCLC)

    go.drugbank.com/conditions/DBCOND0145711
    Drugs: Nintedanib
    Synonyms: Locally recurrent Non-Small Cell Lung Carcinoma (NSCLC)
  2. Indication

    Metastatic EGFR Positive Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0173472
    Drugs: Datopotamab deruxtecan
    Synonyms: Metastatic EGFR Positive Non-small Cell Lung Cancer
  3. Indication

    Metastatic RET-fusion Non Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0129285
    Drugs: Pralsetinib · Selpercatinib
    Synonyms: Metastatic RET-fusion Non Small Cell Lung Cancer
  4. Indication

    Refractory, locally advanced Non small cell lung cancer

    go.drugbank.com/conditions/DBCOND0025489
    Drugs: Ceritinib · Docetaxel
    Synonyms: Refractory, locally advanced Non-small cell lung cancer, Refractory, locally advanced Non small cell lung cancer
  5. Indication

    Stage 1b Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173418
    Drugs: Pembrolizumab
    Synonyms: Stage 1b Non-Small Cell Lung Cancer (NSCLC)
  6. Indication

    ALK positive Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0167961
    Drugs: Alectinib
    Synonyms: ALK positive Metastatic Non-Small Cell Lung Cancer
  7. Indication

    Ischemia caused by non-q wave myocardial infarction

    go.drugbank.com/conditions/DBCOND0166915
    Drugs: Enoxaparin
    Synonyms: Ischemia caused by non-q wave myocardial infarction
  8. Indication

    Unresectable Stage III Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0123170
    Drugs: Durvalumab
    Synonyms: Unresectable Stage III Non-small Cell Lung Cancer, Unresectable Stage III Non-small-cell Lung Cancer
  9. Indication

    Advanced RET-fusion Non Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0144083
    Drugs: Pralsetinib
    Synonyms: Advanced RET-fusion Non Small Cell Lung Cancer
  10. Indication

    Stage 3 Non-Small Cell Lung Carcinoma (NSCLC)

    go.drugbank.com/conditions/DBCOND0144292
    Drugs: Pembrolizumab
    Synonyms: Stage 3 Non-Small Cell Lung Carcinoma (NSCLC)